scholarly journals Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis

2008 ◽  
Vol 128 (11) ◽  
pp. 2625-2630 ◽  
Author(s):  
Chizuko Koga ◽  
Kenji Kabashima ◽  
Noriko Shiraishi ◽  
Miwa Kobayashi ◽  
Yoshiki Tokura
2018 ◽  
Vol 138 (5) ◽  
pp. S17
Author(s):  
A. Fries ◽  
J. Di Domizio ◽  
O. Demaria ◽  
C. Triboulet ◽  
M. Gilliet
Keyword(s):  

2013 ◽  
Vol 175 (1) ◽  
pp. 25-31 ◽  
Author(s):  
L. Ma ◽  
H.-B. Xue ◽  
X.-H. Guan ◽  
C.-M. Shu ◽  
J.-H. Zhang ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Elisabetta Volpe ◽  
Luca Battistini ◽  
Giovanna Borsellino

The discovery of the T helper (Th) 17 lineage, involved in the protection against fungal and extracellular bacterial infections, has profoundly revolutionized our current understanding of T cell-mediated responses in autoimmune diseases, including multiple sclerosis (MS). Indeed, recent data demonstrate the pathogenic role of Th17 cells in autoimmune disorders. In particular, studies in MS and in its animal model (EAE, experimental autoimmune encephalomyelitis) have revealed a crucial role of Th17 cells in the pathogenesis of autoimmune demyelinating diseases in both mice and humans. Over the past years, several important aspects concerning Th17 cells have been elucidated, such as the factors which promote or inhibit their differentiation and the effector cytokines which mediate their responses. The identification of the features endowing Th17 cells with high pathogenicity in MS is of particular interest, and discoveries in Th17 cell biology and function could lead to the design of new strategies aimed at modulating the immune response in MS. Here, we will discuss recent advances in this field, with particular focus on the mechanisms conferring pathogenicity in MS and their potential modulation.


2012 ◽  
Vol 68 (1) ◽  
pp. 66-68 ◽  
Author(s):  
Lei Ma ◽  
Hai-Bo Xue ◽  
Xiu-Hao Guan ◽  
Rui-Qun Qi ◽  
Rong-Zhen An ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document